نتائج البحث - "Ezhilarasan, Devaraj"

1

دورية أكاديمية

Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD.

المصدر: Metabolism: Clinical & Experimental; Jun2024, Vol. 155, pN.PAG-N.PAG, 1p

مصطلحات موضوعية: NUCLEAR factor E2 related factor, INSULIN, STEROL regulatory element-binding proteins, NF-kappa B, LEPTIN receptors, HEPATIC fibrosis, NON-alcoholic fatty liver disease

2

دورية أكاديمية

Relaxin in hepatic fibrosis: What is known and where to head?

المؤلفون: Ezhilarasan, Devaraj¹ (AUTHOR) ezhilarasand.sdc@saveetha.com

المصدر: Biochimie. Aug2021, Vol. 187, p144-151. 8p.

مصطلحات موضوعية: *HEPATIC fibrosis, *PEPTIDE hormones, *RELAXIN, *LIVER cells, *MATRIX metalloproteinases, *COLLAGEN, *TRANSFORMING growth factors-beta

3

دورية أكاديمية

Oxidative stress is bane in chronic liver diseases: Clinical and experimental perspective.

المؤلفون: Ezhilarasan, Devaraj

المصدر: Arab Journal of Gastroenterology; Jun2018, Vol. 19 Issue 2, p56-64, 9p

4

دورية أكاديمية

Molecular mechanisms in thioacetamide-induced acute and chronic liver injury models.

المؤلفون: Ezhilarasan, Devaraj¹ (AUTHOR) ezhild@gmail.com

المصدر: Environmental Toxicology & Pharmacology. Apr2023, Vol. 99, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *HEPATIC fibrosis, *LIVER injuries, *TRANSFORMING growth factors, *LIVER cells, *LIPID peroxidation (Biology), *VENOUS pressure

5

دورية أكاديمية

Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients.

المؤلفون: Gheena, Sukumaran¹ (AUTHOR), Ezhilarasan, Devaraj² (AUTHOR) ezhild@gmail.com

المصدر: Oral Oncology. Feb2023, Vol. 137, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *CANCER vaccines, *ORAL cancer, *THERAPEUTICS, *CANCER patients, *IPILIMUMAB

6

دورية أكاديمية

Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.

المؤلفون: Ezhilarasan, Devaraj¹ (AUTHOR) ezhilarasand.sdc@saveetha.com, Najimi, Mustapha² (AUTHOR)

المصدر: Critical Reviews in Oncology/Hematology. Feb2023, Vol. 182, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *LIVER cells, *CANCER cells, *MYELOID-derived suppressor cells, *REGULATORY T cells, *TUMOR microenvironment

النص الكامل

7

دورية أكاديمية

Silibinin Inhibits Proliferation and Migration of Human Hepatic Stellate LX-2 Cells.

المؤلفون: Ezhilarasan, Devaraj¹, Evraerts, Jonathan¹, Brice, Sid², Buc-Calderon, Pedro³, Karthikeyan, Sivanesan⁴, Sokal, Etienne¹, Najimi, Mustapha¹ mustapha.najimi@uclouvain.be

المصدر: Journal of Clinical & Experimental Hepatology. Sep2016, Vol. 6 Issue 3, p167-174. 8p.

مصطلحات موضوعية: *SILIBININ, *KUPFFER cells, *FIBROSIS, *CELL proliferation, *PEROXISOME proliferator-activated receptors

النص الكامل

8

دورية أكاديمية

Restoring the anti-tumor property of PTEN: A promising oral cancer treatment.

المؤلفون: Shree Harini, Karthik¹ (AUTHOR), Ezhilarasan, Devaraj¹ (AUTHOR) ezhilarasand.sdc@saveetha.com, Elumalai, Perumal¹ (AUTHOR)

المصدر: Oral Oncology. Nov2022, Vol. 134, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *ORAL cancer, *CANCER treatment, *MOUTH tumors, *PHOSPHATASES

9

دورية أكاديمية

Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma.

المؤلفون: Elumalai, Perumal¹ (AUTHOR), Ezhilarasan, Devaraj¹ (AUTHOR) ezhild@gmail.com

المصدر: Oral Oncology. Nov2022, Vol. 134, pN.PAG-N.PAG. 1p.

مصطلحات موضوعية: *SQUAMOUS cell carcinoma, *GENOME editing, *DRUG resistance, *CRISPRS, *ORAL medication, *P16 gene, *MOUTH tumors, *HEAD & neck cancer, *GENE expression, *TECHNOLOGY

10

دورية أكاديمية

Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy.

المؤلفون: Ezhilarasan, Devaraj¹ (AUTHOR) ezhild@gmail.com, Shree Harini, Karthik² (AUTHOR)

المصدر: Oral Oncology. Oct2022, Vol. 133, pN.PAG-N.PAG. 1p.

تنقيح النتائج